Cell autonomous or systemic EGFR blockade alters the immune-environment in squamous cell carcinomas

Targeting mutations and amplifications in the EGFR has been successful precision therapy for cancers of the lung, oral cavity and gastrointestinal track. However, a systemic immune reaction manifested by dose-limiting inflammation in the skin and gut has been a consistent adverse effect. To address...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Cancer
Asıl Yazarlar: Mascia, Francesca, Schloemann, Derek T., Cataisson, Christophe, McKinnon, Katherine M., Krymskaya, Ludmila, Wolcott, Karen M., Yuspa, Stuart H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5028304/
https://ncbi.nlm.nih.gov/pubmed/27509256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.30376
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller